Re-analysis of the Nieto et al. 2021 pan-cancer Tumour Immune Cell Atlas (CD226/DNAM signature scoring)
-
Updated
Jul 14, 2026 - R
Re-analysis of the Nieto et al. 2021 pan-cancer Tumour Immune Cell Atlas (CD226/DNAM signature scoring)
Analysis code (by Dillon Corvino) for Braun et al. — CD155 drives immunotherapy resistance via CD226 degradation in CD8+ T cells. Immunity 2020.
To associate your repository with the cd226 topic, visit your repo's landing page and select "manage topics."